10/10/25 17:40  | 10/8/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S.m | -4,383 | 54.79 | 0 | -80 | -1 | 5,697 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/8/25 18:05  | 9/4/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S.m | -4,176 | 52.20 | 0 | -80 | -1 | 5,777 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/22/25 16:46  | 8/20/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S | -1,277 | 48.82 | 0 | -26 | 0 | 5,857 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/19/25 19:38  | 8/16/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 65 | 1 | 5,883 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/11/25 18:12  | 8/7/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S.m | -3,667 | 45.84 | 0 | -80 | -1 | 5,852 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/3/25 16:30  | 7/1/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S.m | -3,410 | 42.63 | 0 | -80 | -1 | 5,932 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/20/25 18:06  | 5/16/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 65 | 1 | 6,012 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/20/25 18:06  | 5/19/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S.dm | -3,377 | 33.38 | 0 | -101 | -2 | 6,012 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/24/25 16:28  | 4/22/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S | -2,558 | 34.11 | 0 | -75 | -1 | 6,081 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/27/25 16:54  | 3/25/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S | -2,765 | 36.87 | 0 | -75 | -1 | 6,156 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/27/25 17:12  | 2/25/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S | -2,518 | 33.57 | 0 | -75 | -1 | 6,231 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/19/25 20:48  | 2/16/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 56 | 1 | 6,306 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/19/25 20:48  | 2/19/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S.d | -1,140 | 36.14 | 0 | -32 | 0 | 6,306 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/30/25 18:29  | 1/28/25  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S.m | -21,789 | 36.31 | 0 | -600 | -9 | 6,306 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/20/24 20:00  | 11/19/24  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S | -614 | 22.41 | 0 | -27 | 0 | 6,906 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/19/24 18:15  | 11/16/24  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 56 | 1 | 6,933 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/20/24 18:31  | 8/16/24  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 56 | 1 | 6,906 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/20/24 18:31  | 8/19/24  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | S.d | -676 | 24.69 | 0 | -27 | 0 | 6,906 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/17/24 16:11  | 5/16/24  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 61 | 1 | 6,906 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/21/24 16:03  | 2/16/24  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 102 | 2 | 6,876 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/20/23 16:00  | 11/16/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 102 | 2 | 6,822 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/20/23 16:00  | 11/17/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -1,500 | 29.10 | 0 | -52 | -1 | 6,822 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/23 16:00  | 8/16/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 102 | 2 | 6,822 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/23 16:00  | 8/17/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -1,474 | 28.59 | 0 | -52 | -1 | 6,822 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/23 16:07  | 5/16/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 102 | 2 | 6,822 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/23 16:07  | 5/17/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -722 | 14.01 | 0 | -52 | -1 | 6,822 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/5/23 16:03  | 5/3/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,702 | 14.18 | 0 | -120 | -2 | 6,822 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/7/23 16:39  | 4/5/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,856 | 15.46 | 0 | -120 | -2 | 6,942 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/3/23 20:01  | 3/3/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,315 | 10.96 | 0 | -120 | -2 | 7,062 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/21/23 20:12  | 2/16/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 69 | 1 | 7,182 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/21/23 20:12  | 2/17/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -569 | 12.70 | 0 | -45 | -1 | 7,182 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/6/23 19:26  | 2/3/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,321 | 11.01 | 0 | -120 | -2 | 7,182 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/6/23 20:35  | 1/5/23  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -921 | 7.67 | 0 | -120 | -2 | 7,302 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/21/22 19:58  | 12/21/22  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | 0 | 0.00 | 0 | -200 | -3 | 7,422 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/18/22 18:42  | 11/16/22  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 69 | 1 | 7,622 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/18/22 18:42  | 11/17/22  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -326 | 9.40 | 0 | -35 | 0 | 7,622 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/22 18:39  | 8/16/22  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 69 | 1 | 7,622 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/22 16:06  | 5/16/22  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 69 | 1 | 7,581 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/18/22 16:35  | 2/16/22  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 0 | 7,536 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/18/21 16:05  | 11/16/21  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 0 | 7,531 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/21 16:06  | 8/16/21  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 0 | 7,527 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/21 18:29  | 5/16/21  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 8 | 0 | 7,524 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/18/21 19:45  | 2/16/21  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 5 | 0 | 7,520 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/18/20 19:51  | 11/16/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 5 | 0 | 7,705 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/20 19:02  | 8/16/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | M.d | 0 | 0.00 | 0 | 5 | 0 | 7,702 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/5/20 18:47  | 8/3/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -2,178 | 27.23 | 0 | -80 | -1 | 7,699 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/6/20 19:18  | 7/1/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -4,411 | 30.75 | 0 | -143 | -2 | 7,779 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/10/20 16:09  | 6/8/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -318 | 30.01 | 0 | -11 | 0 | 7,922 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/5/20 19:55  | 6/3/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.d | -178 | 30.05 | 0 | -6 | 0 | 7,933 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/3/20 16:06  | 6/1/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -2,335 | 29.19 | 0 | -80 | -1 | 7,939 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/6/20 20:21  | 5/5/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -2,469 | 31.02 | 0 | -80 | -1 | 8,019 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/5/20 16:05  | 5/1/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -2,364 | 29.40 | 0 | -80 | -1 | 8,098 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/9/20 16:05  | 4/7/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -46 | 25.48 | 0 | -2 | 0 | 8,179 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/6/20 21:17  | 4/3/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -8 | 25.09 | 0 | 0 | 0 | 8,181 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/3/20 16:10  | 4/1/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -2,026 | 26.02 | 0 | -78 | -1 | 8,181 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/20 17:55  | 3/2/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S.m | -3,874 | 32.28 | 0 | -120 | -1 | 8,259 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/7/20 17:40  | 2/5/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO,P | S | -1,077 | 34.87 | 0 | -31 | 0 | 8,378 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/5/20 17:04  | 2/3/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | See Rema | S.m | -3,092 | 34.70 | 0 | -89 | -1 | 8,409 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/6/20 21:15  | 1/2/20  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | See Rema | S.m | -3,902 | 32.52 | 0 | -120 | -1 | 8,832 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/8/19 21:32  | 7/3/19  | EIDX | Eidos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DOT | CEO | P | 26,383 | 29.90 | 0 | 882 | 4 | 24,576 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/3/19 16:12  | 7/1/19  | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | See Rema | M.d | 0 | 0.00 | 0 | 8,952 |  | 8,552 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/29/19 19:15  | 5/24/19  | EIDX | Eidos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DOT | CEO | P | 28,623 | 25.93 | 0 | 1,104 | 5 | 23,693 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/22/18 18:56  | 6/22/18  | EIDX | Eidos Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DOT | CEO | P.d | 17,000 | 17.00 | 0 | 1,000 | 5 | 19,615 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  |